Symmetrix PX Spinal System
MEDTRONIC SOFAMOR DANEK USA, INC. · Decision date Oct 29, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on October 29, 2026 for the Symmetrix™ PX Spinal System, a traditional 510(k) submitted by Medtronic Sofamor Danek USA, Inc. under K262572. The device is an intervertebral body fusion device (product code MAX, 21 CFR 888.3080, Class II, orthopedic panel) made of titanium alloy, cobalt chromium alloy, and PEEK, offered in varied widths, lengths, heights and lordotic angles, with optional Titan Surface Technology textures and compatibility with Medtronic Stealth™ navigation. SE denotes clearance to market, not PMA approval.
The submission lists the Catalyft™ PL Expandable Interbody System as primary predicate, with Catalyft™ LS, Adaptix, and Globus Rise Spacer as additional predicates. The summary reports bench testing (ASTM F2077, F2267, F2503) meeting predicate-derived acceptance criteria and MR Conditional labeling. The indications enclosure is referenced but not reproduced in the available text, so the cleared indications wording is not verified here; the summary's stated lumbar L2-S1 indications should be checked against that enclosure.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262572
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- MEDTRONIC SOFAMOR DANEK USA, INC.
- Product code
- MAX
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intervertebral Fusion Device With Bone Graft, Lumbar.
- Applicant
- Medtronic Sofamor DANEK USA, Inc.
- Product code
- MAX
- FDA device class
- 2
FDA decision timeline
K262572 received
Application receipt date recorded by FDA.
K262572 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MAX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Solco Biomedical Company India Private Limited | 510(k) clearance | Nov 6, 2026 | FDA | |
| Alphatec Spine, Inc. | 510(k) clearance | Oct 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Sofamor DANEK USA, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- Memphis, TN
Sources and methodology
- Original FDA record: K262572
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
